Ravdeep Singh Anand

Ravdeep Singh Anand

Active Director Director DIN 05010847
DIN 05010847 First appointment Nov 2010 Primary industry Life Sciences
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Past companies 2 historical roles
Total affiliations 4 Since Nov 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Ravdeep Singh Anand

Data last updated:

Ravdeep Singh Anand is a Director at Hanugen Therapeutics Private Limited (since 2017) and Director at Krm Ananda Ventures Private Limited (since 2025). The companies operate in Life Sciences. The largest current company by reported revenue is Hanugen Therapeutics Private Limited at ₹1.23 Cr (FY 2025). Earlier, Ravdeep Singh Anand was a Director at Genophe Biotech Private Limited (2018–2020) and Designated Partner at Rpr Solutions Llp (from 2010).

DIN 05010847
Primary Designation Director
Industry Life Sciences
First Appointment 04 Nov 2010
Oldest Company Age 16 yrs
Largest company Hanugen Therapeutics Private Limited Β· ₹1.23 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hanugen Therapeutics Private Limited U73200KA2017PTC100686
Director20 Feb 20172017₹1.23 Cr (FY 2025)Active
Krm Ananda Ventures Private Limited U68200KA2025PTC213088
Director23 Dec 20252025Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Genophe Biotech Private Limited U73200KA2018PTC109240
Director05 Jan 20182018₹44,240 (FY 2024)Active
Designated Partner04 Nov 20102010Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Ravdeep Singh Anand

Directorship timeline

Open interactive timeline →
Rpr Solutions Llp
Krm Ananda Ventures Private Limited
Hanugen Therapeutics Private Limited
Genophe Biotech Private Limited
Premium access

Shareholding and investment profile for Ravdeep Singh Anand

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravdeep Singh Anand

Ravdeep Singh Anand currently holds 2 directorships: Hanugen Therapeutics Private Limited (Director, since 20 Feb 2017, revenue β‚Ή1.23 Cr (FY 2025)); Krm Ananda Ventures Private Limited (Director, since 23 Dec 2025).

Ravdeep Singh Anand was first appointed on 04 Nov 2010 as Designated Partner at Rpr Solutions Llp. The most recent appointment on record is 23 Dec 2025 at Krm Ananda Ventures Private Limited.

Ravdeep Singh Anand held 2 earlier board appointments: Genophe Biotech Private Limited (Director, 05 Jan 2018 to 13 Mar 2020); Rpr Solutions Llp (Designated Partner, from 04 Nov 2010).

The current boards of Ravdeep Singh Anand's companies include Arun Shastry (Hanugen Therapeutics Private Limited), Manjulam (Hanugen Therapeutics Private Limited), Movin Anand (Krm Ananda Ventures Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available